A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction

Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings

Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1037/e560352009-001 · Cited by 6,930

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733

Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors

Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,531

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

Mattick, R. P., Breen, C. L., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,312

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654

Monitoring the Future national survey results on drug use, 1975-2016: Volume II, college students and adults ages 19-55

Volume, I. I. (2017) · Institute for Social Research eBooks · doi:10.3998/2027.42/139710 · Cited by 1,369

A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders

Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287

Results from the 2003 National Survey on Drug Use and Health: National Findings

(2004) · PsycEXTRA Dataset · doi:10.1037/e400442005-001 · Cited by 1,245

Characterizing Long-Term Health Related Quality of Life Trajectories of Individuals With Opioid Use Disorder

Krebs, E., Kerr, T. H., Wood, E., & Nosyk, B. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.05.001 · Cited by 25

Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators

Ma, H., Obeng, S., Wang, H., Zheng, Y., Li, M., Jali, A. M., Stevens, D. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01767 · Cited by 26

Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists

Pagare, P. P., Li, M., Zheng, Y., Kulkarni, A. S., Obeng, S., Huang, B., Ruiz, C., Gillespie, J. C., Mendez, R. E., Stevens, D. L., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00087 · Cited by 26

Human resource development and capacity-building during China’s rapid scale-up of methadone maintenance treatment services

Li, J., Wang, C., McGoogan, J. M., Rou, K., Bulterys, M., & Wu, Z. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.108951 · Cited by 24

A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients

Chang, H., Krawczyk, N., Schneider, K. E., Ferris, L. M., Eisenberg, M. D., Richards, T. M., Lyons, B. C., Jackson, K., Weiner, J. P., & Saloner, B. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.04.016 · Cited by 25

Bidirectional relationship between heroin addiction and depression: Behavioural and neural studies

Moustafa, A. A., Tindle, R., Cashel, S., Parkes, D., Mohamed, E., & Hamza, E. A. (2020) · Current Psychology · doi:10.1007/s12144-020-01032-4 · Cited by 28

A computerized anxiety sensitivity intervention for opioid use disorders: A pilot investigation among veterans

Raines, A. M., Allan, N. P., McGrew, S. J., Gooch, C. V., Wyatt, M., Laurel Franklin, C., & Schmidt, N. B. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106285 · Cited by 22

m-Trifluoromethyl-diphenyl diselenide (m-CF3-PhSe)2 modulates the hippocampal neurotoxic adaptations and abolishes a depressive-like phenotype in a short-term morphine withdrawal in mice

Martins, C. C., Rosa, S. G., Recchi, A. M. S., Nogueira, C. W., & Zeni, G. R. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109803 · Cited by 21

Kratom Dependence and Treatment Options: A Comprehensive Review of the Literature

Abdullah, M. F. I. L. B. (2020) · Current Drug Targets · doi:10.2174/1389450121666200719011653 · Cited by 22

Do Gender Differences in Depression Remain after Controlling for Early Maladaptive Schemas? An Examination in a Sample of Opioid Dependent Treatment Seeking Adults

Shorey, R. C., Stuart, G. L., & Anderson, S. T. (2012) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.1772 · Cited by 28

Empirical Studies Addressing the Opioid Epidemic: An Urgent Call for Research

Stuart, G. L., Shorey, R. C., France, C. R., Macfie, J., Bell, K. M., Fortner, K. B., Towers, C. V., Schkolnik, P., & Ramsey, S. E. (2018) · Substance Abuse Research and Treatment · doi:10.1177/1178221818784294 · Cited by 24

A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders

Camlin, T. J., Eulert, D., Horvath, A. T., Bucky, S. F., Barsuglia, J. P., & Polanco, M. (2018) · Journal of Psychedelic Studies · doi:10.1556/2054.2018.004 · Cited by 21

When the Brain Leaves the Scanner and Enters the Clinic

Barnett, A., Dilkes‐Frayne, E., Savic, M., & Carter, A. (2018) · Contemporary Drug Problems · doi:10.1177/0091450918774918 · Cited by 20

A Randomized, Controlled Trial of the Efficacy of an Interoceptive Exposure-Based CBT for Treatment-Refractory Outpatients with Opioid Dependence

Otto, M. W., Hearon, B. A., McHugh, R. K., Calkins, A. W., Pratt, E. M., Latin, H. M., Safren, S. A., & Pollack, M. H. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.960110 · Cited by 19

Prevalence of Pain Among Nonmedical Prescription Opioid Users in Substance Use Treatment Populations: Systematic Review and Meta-analyses

Fischer, B. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/e671 · Cited by 19

A comparison of patients with opioid use disorder receiving buprenorphine treatment with and without peer recovery support services

Mills-Huffnagle, S. L., Brennan, G. M., Wicks, K., Holden, D., & Kawasaki, S. S. (2021) · Journal of Substance Use · doi:10.1080/14659891.2021.1938265 · Cited by 19

Effect of Sinomenine on the Morphine-Dependence and Related Neural Mechanisms in Mice

Fang, M., Li, J., Zhu, D., Luo, C., Li, C., Zhu, C. Y., Fan, M., Yung, K. K. L., & Mo, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2407-5 · Cited by 19

Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore

Song, G., Manning, V., Yang, Y., Koh, P. K., Chan, E. S., de Souza, N. N., Assam, P. N., Sultana, R., Wijesinghe, R., Pangjaya, J., et al. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.04.012 · Cited by 19

Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients

Waddy, S. P., Becerra, A. Z., Ward, J. B., Chan, K. E., Fwu, C., Eggers, P. W., Abbott, K. C., & Kimmel, P. L. (2020) · American Journal of Nephrology · doi:10.1159/000507725 · Cited by 19

From Resistance to Existence—Experiences of Medication-Assisted Treatment as Disclosed by People with Opioid Dependence

Lindgren, B., Eklund, M., Melin, Y., & Graneheim, U. H. (2015) · Issues in Mental Health Nursing · doi:10.3109/01612840.2015.1074769 · Cited by 19

Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine

Isaza, C., Henao, J., Beltrán, L., Porras-Hurtado, L., Gonzalez, M., Cruz, R., & Carracedo, Á. (2013) · Colombia medica · doi:10.25100/cm.v44i1.1039 · Cited by 19

Effects of treatment status and life quality on anxiety in MMT patients

Cao, P., Zhang, Z., Zhong, J., Xu, S., Huang, Q., & Fan, N. (2021) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-021-00343-4 · Cited by 18

A sham-controlled clinical trial to examine the effect of bilateral tDCS on craving, TNF-α and IL-6 expression levels, and impulsivity of males with opioid use disorder

Eskandari, Z., Mostafavi, H., Hosseini, M., Mousavi, S. E., Ramazani, S., & Dadashi, M. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1883208 · Cited by 18

Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks

Feng, H., Elladki, R., Jian, J., & Wei, G. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106745 · Cited by 18

TIDAL: Topology-Inferred Drug Addiction Learning

Zhu, Z., Dou, B., Cao, Y., Jiang, J., Zhu, Y., Chen, D., Feng, H., Liu, J., Zhang, B., Zhou, T., et al. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00046 · Cited by 18

Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like Effect

Bello, F. D., Diamanti, E., Giannella, M., Mammoli, V., Marchioro, C., Mattioli, L., Titomanlio, F., Piergentili, A., Quaglia, W., Benedetti, G., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300064v · Cited by 18

Prescription Drug Abuse as a Public Health Problem in Ohio: A Case Report

Winstanley, E. L., Gay, J., Roberts, L., Moseley, J., Hall, O. T., Beeghly, B. C., Winhusen, T. M., & Somoza, E. C. (2012) · Public Health Nursing · doi:10.1111/j.1525-1446.2012.01043.x · Cited by 18

Antagonism of the D1- and D2-like dopamine receptors in the nucleus accumbens attenuates forced swim stress- and morphine priming-induced reinstatement of extinguished rats

Farzinpour, Z., Mousavi, Z., Karimi‐Haghighi, S., & Haghparast, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.010 · Cited by 19

Neuropsychiatric implications of transient receptor potential vanilloid (TRPV) channels in the reward system

Singh, R., Bansal, Y., Parhar, I. S., Kuhad, A., & Soga, T. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104545 · Cited by 18

Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy

Harun, N., Kamaruzaman, N. A., Sofian, Z. M., & Hassan, Z. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136500 · Cited by 16

Modeling the Dynamics of Heroin and Illicit Opioid Use Disorder, Treatment, and Recovery

Cole, S., & Wirkus, S. A. (2022) · Bulletin of Mathematical Biology · doi:10.1007/s11538-022-01002-w · Cited by 18

The Impact of Qigong and Tai Chi Exercise on Drug Addiction: A Systematic Review and Meta-Analysis

Cui, J., Liu, F., Liu, X., Li, R., Chen, X., & Zeng, H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.826187 · Cited by 20

Differences in early maladaptive schemas in a sample of alcohol- and opioid-dependent women: Do schemas vary across disorders?

Shorey, R. C., Stuart, G. L., & Anderson, S. T. (2012) · Addiction Research & Theory · doi:10.3109/16066359.2012.703266 · Cited by 17

Opioid Dependence and NMDA Receptors

Glass, M. J. (2011) · ILAR Journal · doi:10.1093/ilar.52.3.342 · Cited by 17

Effect of cognitive behavioural interventions on the quality of life in Chinese heroin‐dependent individuals in detoxification: a randomised controlled trial

Zhuang, S., An, S., & Zhao, Y. (2013) · Journal of Clinical Nursing · doi:10.1111/jocn.12287 · Cited by 17

Actigraphic Measurements in Opioid Detoxification With Methadone or Buprenorphine

Pjrek, E., Frey, R., Naderi‐Heiden, A., Strnad, A., Kowarik, A., Kasper, S. F., & Winkler, D. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f91d1 · Cited by 17

Psychiatric Comorbidity and Personality Structure in Patients with Polyvalent Addiction

Rentrop, M., Zilker, T. R., Lederle, A., Birkhofer, A., & Hörz‐Sagstetter, S. (2013) · Psychopathology · doi:10.1159/000351784 · Cited by 17

Situational and psycho-social factors associated with relapse following residential detoxification in a population of Irish opioid dependent patients

Ducray, K., Darker, C. D., & Smyth, B. P. (2012) · Irish Journal of Psychological Medicine · doi:10.1017/s079096670001733x · Cited by 17

Impact of social media-based intervention in reducing youths’ propensity to engage in drug abuse in Nigeria

Ahmad, J., Ugwuoke, J. C., Talabi, F. O., Bibian, O. N., Aiyesimoju, A. B., Adefemi, V. O., & Gever, V. C. (2022) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2022.102122 · Cited by 20

Baseline characteristics of patients predicting suitability for rapid naltrexone induction

Mogali, S., Khan, N. A., Drill, E. S., Pavlicová, M., Sullivan, M. A., Nunes, E. V., & Bisaga, A. M. (2015) · American Journal on Addictions · doi:10.1111/ajad.12180 · Cited by 16

A Systematic Review of Psychosocial Interventions in Treatment of Opioid Addiction

Brown, A. (2018) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2018.1485574 · Cited by 22

Gender-Specific Predictors of Methadone Treatment Outcomes among African Americans at An Urban Clinic

Lister, J. J., Brown, S., Greenwald, M. K., & Ledgerwood, D. M. (2019) · Substance Abuse · doi:10.1080/08897077.2018.1547810 · Cited by 16

Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy

Newville, H., Roley, J., & Sorensen, J. L. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.07.013 · Cited by 16

Differential expression of endocannabinoid system-related genes in the dorsal hippocampus following expression and reinstatement of morphine conditioned place preference in mice

Li, W. X., Zhang, C.-L., & Qiu, Z. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.025 · Cited by 16

Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005–2016

Fischer, B., Jones, W. R., Varatharajan, T., Malta, M., & Kurdyak, P. A. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.09.001 · Cited by 17

Cognitive Impairment in Opium Use Disorder

Moghaddam, H. S., Shadloo, B., Shahkhah, H., Tafakhori, A., Haghshomar, M., Meshkat, S., & Aghamollaii, V. (2021) · Behavioural Neurology · doi:10.1155/2021/5548623 · Cited by 18

Comparing the Efficacy of Anodal, Cathodal, and Sham Transcranial Direct Current Stimulation on Brain-derived Neurotrophic Factor and Psychological Symptoms in Opioid-addicted Patients

Eskandari, Z., Dadashi, M., Mostafavi, H., Kia, A. A., & Pirzeh, R. (2019) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.10.6.1710.1 · Cited by 15

Trait mindfulness and early maladaptive schemas in women seeking residential substance use treatment: A preliminary investigation

Shorey, R. C., Anderson, S. T., & Stuart, G. L. (2014) · Addiction Research & Theory · doi:10.3109/16066359.2014.981810 · Cited by 15

Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand

Zhang, Y., Braithwaite, A., Yuan, Y., Streicher, J. M., & Bilsky, E. J. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.04.041 · Cited by 14

Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment

Huang, B., Li, M., Klongkumnuankarn, P., Mendez, R. E., Gillespie, J. C., Stevens, D. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02185 · Cited by 13

Adolescents at Risk: Pain Pills to Heroin: Part I

Fogger, S. A., & McGuinness, T. M. (2014) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20141114-01 · Cited by 12

Administration of the Glial Condition Medium in the Nucleus Accumbens Prolong Maintenance and Intensify Reinstatement of Morphine-Seeking Behavior

Arezoomandan, R., Khodagholi, F., & Haghparast, A. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1762-3 · Cited by 12

Rhynchophylline downregulates phosphorylated camp response element binding protein, nuclear receptor-related-1, and brain-derived neurotrophic factor expression in the hippocampus of ketamine-induced conditioned place preference rats

Yung, K. K. L., Mo, Z., Guo, Y., Luo, C., Tu, G., Li, C., Liu, Y., & Liu, W. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_90_17 · Cited by 13

Exploring Multitarget Interactions to Reduce Opiate Withdrawal Syndrome and Psychiatric Comorbidity

Bello, F. D., Diamanti, E., Giannella, M., Mammoli, V., Mattioli, L., Titomanlio, F., Piergentili, A., Quaglia, W., Lanza, M., Sabatini, C., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400232p · Cited by 11

Education, Personal Experiences, and Advocacy

Niu, S., McKim, K. G., & Reed, K. M. P. (2022) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3555624 · Cited by 11

Effects of 8 months of high-intensity interval training on physical fitness and health-related quality of life in substance use disorder

Tan, J., Wang, J., Yin, G., Lü, C., Tang, W., & Zheng, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1093106 · Cited by 11

Modelling Long-Term Joint Trajectories of Heroin Use and Treatment Utilisation: Findings from the Australian Treatment Outcome Study

Marel, C., Mills, K. L., Slade, T. N., Darke, S. G., Ross, J. E., & Teesson, M. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.07.013 · Cited by 11

Trajectories of drug treatment and illicit opioid use in the AIDS Linked to the IntraVenous Experience cohort, 2014–2019

Rudolph, J. E., Cepeda, J., Astemborski, J. A., Kirk, G. D., Mehta, S. H., & Genberg, B. L. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104120 · Cited by 10

Development of an Effective Monoclonal Antibody against Heroin and Its Metabolites Reveals Therapies Have Mistargeted 6-Monoacetylmorphine and Morphine over Heroin

Lee, J. C., Eubanks, L. M., Zhou, B., & Janda, K. D. (2022) · ACS Central Science · doi:10.1021/acscentsci.2c00977 · Cited by 10

Reduction of Opiate Withdrawal Symptoms With Use of Clonidine in a County Jail

Fresquez-Chavez, K. R., & Fogger, S. A. (2014) · Journal of Correctional Health Care · doi:10.1177/1078345814557630 · Cited by 10

Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States

Asche, C. V., Clay, E., Kharitonova, E., Zah, V., Ruby, J., & Aballéa, S. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1036760 · Cited by 10

Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profiles

O’Grady, C. L., Surratt, H. L., Kurtz, S. P., & Levi‐Minzi, M. A. (2014) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-9-9 · Cited by 10

Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems?

Monwell, B., Bülow, P., & Gerdner, A. (2016) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-016-0066-1 · Cited by 10

Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis

Rogal, S. S., Youk, A. O., Agbalajobi, O. M., Zhang, H., Gellad, W. F., Fine, M. J., Belperio, P. S., Morgan, T. R. M., Good, C. B., & Kraemer, K. L. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001228 · Cited by 10

ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment

Fonseca, F., Gratacòs, M., Escaramís, G., de Cid, R., Martín‐Santos, R., Farré, M., Estivill, X., & Torrens, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.003 · Cited by 10

Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?

Kurdyak, P. A., Jacob, B. J., Zaheer, J., & Fischer, B. (2018) · Europe PMC (PubMed Central) · Cited by 10

A Comparison of Suboxone and Methadone in the Treatment of Opiate Addiction

Peddicord, A. N., & Bush, C. (2015) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000248 · Cited by 9

Weaning From Long-term Opioid Therapy

Moss, C., Bossano, C. M., Patel, S., Powell, A. M., Seay, R. C., & Borahay, M. A. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000425 · Cited by 9

Experiences of Clients in Three Types of Methadone Maintenance Therapy in an Atlantic Canadian City: A Qualitative Study

MacNeill, L., Brunelle, C., Skelding, B., & DiTommaso, E. (2020) · Canadian Journal of Nursing Research · doi:10.1177/0844562120924516 · Cited by 9

Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment

Pagare, P. P., Obeng, S., Huang, B., Marcus, M. M., Nicholson, K. L., Townsend, A. E., Banks, M. L., & Zhang, Y. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00178 · Cited by 10

Abstinence versus Agonist Maintenance Treatment: An Outdated Debate?

Uchtenhagen, A. (2013) · European Addiction Research · doi:10.1159/000350373 · Cited by 9

Opioid substitution treatment, relapse and addiction-related outcomes in prison setting and after release: A longitudinal study

Geißelsöder, K., Weiss, M., Boksán, K., Dechant, M., Endres, J., Breuer, M. M., Stemmler, M., & Wodarz, N. (2024) · Nordic Studies on Alcohol and Drugs · doi:10.1177/14550725241276309 · Cited by 8

Treating Opioid Use Under California's Proposition 36: Differential Outcomes by Treatment Modality

Conner, B. T., Hampton, A. S., Hunter, J., & Urada, D. I. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.602281 · Cited by 8

Promising immunomodulators for management of substance and alcohol use disorders

Acuña, A. M., Park, C., Leyrer‐Jackson, J. M., & Olive, M. F. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2360653 · Cited by 10

Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation

Arita, H., Tanaka, R., Kikukawa, S., Tomizawa, T., Sakata, H., Funada, M., Tomiyama, K., Hashimoto, M., Tasaka, T., Tabata, H., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00935 · Cited by 8

Sustained-release naltrexone for opioid dependence

Kornør, H., Lobmaier, P. P. K., & Kunøe, N. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006140.pub3 · Cited by 9

A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice

Bai, Y., Chu, Q., Li, J., Chen, Y.-Y., Li, W., & Zhang, Q. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.08.004 · Cited by 8

Dynamics of heroin molecule inside the lipid membrane: a molecular dynamics study

Singh, S. (2019) · Journal of Molecular Modeling · doi:10.1007/s00894-019-4002-y · Cited by 8

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Martı́nez-Raga, J., González‐Sáiz, F., Oñate, J., Oyagüez, I., Cabrera, E. S., & Casado, M. Á. (2012) · Health Economics Review · doi:10.1186/2191-1991-2-3 · Cited by 7

The opioid epidemic: Mobilizing an academic health center to improve outcomes

Kawasaki, S. S., Dunham, E., Mills, S., Kunkel, E. J. S., & Gonzalo, J. D. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108199 · Cited by 8

Monoclonal Antibodies Engineered with Fc Region Mutations to Extend Protection against Fentanyl Toxicity

Khaimraj, A., Baehr, C., Hicks, D. M., Raleigh, M. D., & Pravetoni, M. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400170 · Cited by 7

The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography

Scott, K., Guigayoma, J. P., Palinkas, L. A., Beaudoin, F. L., Clark, M. A., & Becker, S. J. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00327-0 · Cited by 7

Quetiapine attenuates the acquisition of morphine-induced conditioned place preference and reduces ERK phosphorylation in the hippocampus and cerebral cortex

Khezri, A., Mohsenzadeh, M. S., Mirzayan, E., Bagherpasand, N., Fathi, M., Abnous, K., Imenshahidi, M., Mehri, S., & Hosseinzadeh, H. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2069574 · Cited by 7

Opioid Addiction: Short- and Long-Acting Opioids

Torrens, M., Fonseca, F., Galindo, L., & Farré, M. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_20 · Cited by 8

Methadone enhances human influenza A virus replication

Chen, Y., Wu, K., Tsai, M., Chien, W., Chen, M., & Wang, Y. (2015) · Addiction Biology · doi:10.1111/adb.12305 · Cited by 7

Advancing Addiction Treatment: What Can We Learn from Animal Studies?

Wu, P. H., & Schulz, K. M. (2012) · ILAR Journal · doi:10.1093/ilar.53.1.4 · Cited by 7

Addiction syndrome: Relapse and relapse prevention.

Hsu, S., & Marlatt, G. A. (2012) · American Psychological Association eBooks · doi:10.1037/13750-005 · Cited by 7

Associations between baseline opioid use disorder severity, mental health and biopsychosocial functioning, with clinical responses to computer-assisted therapy treatment

Elison, S., Märtens, K., Yau, C., Davies, G., & Ward, J. (2021) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2020.1861618 · Cited by 7

CARACTERÍSTICAS DEMOGRÁFICAS E DE CONSUMO EM PACIENTES VICIADOS EM HEROÍNA OU DERIVADOS DA COCAÍNA

Isaza, C. A., Suárez, P., Henao, J., & González, M. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.33132/01248146.245 · Cited by 7

Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder

Maciá, V. P., Cortes, M. M., Mesones, J., Segura-Trepichio, M., & Fernandez, L. G. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s277861 · Cited by 6

Opioid Agonist Treatment Recipients within Criminal Justice-Involved Populations

Guastaferro, W. P., Koetzle, D., Lutgen-Nieves, L., & Teasdale, B. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2034869 · Cited by 6

Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction

Giusepponi, M. E., Cifani, C., Bonaventura, M. V. M. D., Mattioli, L., Hudson, A. L., Diamanti, E., Bello, F. D., Giannella, M., Mammoli, V., Paoletti, C. D., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00290 · Cited by 6

Cardiovascular effects of methadone and concomitant use of diazepam during methadone maintenance treatment induction: low concentration risk

Mijatović, V., Samojlik, I., Petković, S., Vukmirović, S., Uvelin, A., & Dickov, A. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1382470 · Cited by 6

Transcranial Direct Current Stimulation to Prevent and Treat Surgery-Induced Opioid Dependence: A Systematic Review

Gallucci, A., de Lucena, P. H. M., Martens, G., Thibaut, A., & Fregni, F. (2018) · Pain Management · doi:10.2217/pmt-2018-0053 · Cited by 6

Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT)

MacNeill, L., Brunelle, C., DiTommaso, E., & Skelding, B. (2019) · Journal of Substance Use · doi:10.1080/14659891.2019.1704083 · Cited by 6

Effect of Topiramate on Morphine-induced Conditioned Place Preference (CPP) in Rats: Role of ERK and CREB Proteins in Hippocampus and Cerebral Cortex.

Bagherpasand, N., Mehri, S., Shahroudi, M. J., Tabatabai, S. M., Khezri, A., Fathi, M., Abnous, K., Imenshahidi, M., & Hosseinzadeh, H. (2019) · PubMed Central · doi:10.22037/ijpr.2019.1100873 · Cited by 6

Naltrexone implant treatment for buprenorphine dependence – Mauritian case series

Jhugroo, A., Ellayah, D., Norman, A. F., & Hulse, G. K. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114528592 · Cited by 6

The “Regulatory Fog” of Opioid Treatment

Wickersham, M. E., & Basey, S. (2016) · Digital Scholarship - Texas Southern University (Texas Southern University) · Cited by 6

Nutritional intake of opioid replacement therapy patients in community pharmacies: A pilot study

Waddington, F., Naunton, M., Kyle, G., & Cooper, G. (2015) · Nutrition & Dietetics · doi:10.1111/1747-0080.12192 · Cited by 5

The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic Potential

Capó, T., Lillo, J., Rebassa, J. B., Badia, P., Raïch, I., Cubeles-Juberias, E., Reyes‐Resina, I., & Navarro, G. (2025) · Brain Sciences · doi:10.3390/brainsci15101105 · Cited by 6

Treatments for Opioid Dependence and Methadone

Bobes-Bascarán, T., Bascarán, T., Al‐Halabí, S., Sáiz, P. A., Bousoño, M., García‐Portilla, M. P., & Bobes, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00060-3

The pharmacological treatment of opioid addiction—a clinical perspective

Lobmaier, P. P. K., Gossop, M., Waal, H., & Bramness, J. G. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0793-6 · Cited by 111

A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction

Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000193 · Cited by 333

Opioid dependence treatment: options in pharmacotherapy

Stotts, A. L., Dodrill, C. L., & Kosten, T. R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903037168 · Cited by 228

New treatments for opiate dependence

Stine, S. M., & Kosten, T. R. (1997) · Guilford Press eBooks · Cited by 19